CHEMOMAB THERAPEUTICS LTD. - AMERICAN DEPOSITARY

1,9800

13-февраля-25 16:45:00

15 мин. задержка

Акции

-0,0300

-1,49%

Сегодняшний диапазон

1,9300 - 2,0620

ISIN

N/A

Источник

NASDAQ

Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update

24 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis

18 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024

02 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis

25 мар 2024 07:06:46 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.